EMTA BRL Indicative Survey Rate definition

EMTA BRL Indicative Survey Rate means, in respect of any date, the USD/BRL foreign exchange rate for USD expressed as the amount of BRL per 1.00 USD, for settlement in two São Paulo and New York Business Days as published on EMTA's website (www.emta.org) at around 12:00 p.m. (São Paulo time) or as soon thereafter as practicable. EMTA BRL Indicative Survey Rate is calculated by EMTA (or a service provider EMTA may select in its sole discretion) pursuant to the EMTA BRL Indicative Survey Methodology (which means a methodology, dated as of 1 March, 2004, as amended from time to time, for a centralised industry-wide survey of financial institutions in Brazil that are active participants in the BRL/USD spot markets for the purpose of determining the EMTA BRL Indicative Survey Rate).
Sample 1Sample 2Sample 3
EMTA BRL Indicative Survey Rate or “BRL13” each means that the Spot Rate for a Rate Calculation Date will be the Brazilian Real/U.S. Dollar Specified Rate for U.S. Dollars, expressed as the amount of Brazilian Reais per one U.S. Dollar, for settlement in two Business Days, as published on EMTA’s web site (www.emta.org) at approximately 12:00 p.m. (São Paulo time), or as soon thereafter as practicable, on such Rate Calculation Date. The Spot Rate shall be calculated by EMTA (or a service provider EMTA may select in its sole discretion) pursuant to the EMTA BRL Indicative Survey Methodology (which means a methodology, dated as of March 1, 2004, as amended from time to time, for a centralized industry-wide survey of financial institutions that are active participants in the Brazilian Real/U.S. Dollar markets for the purpose of determining the EMTA BRL Indicative Survey Rate).
Sample 1Sample 2Sample 3
EMTA BRL Indicative Survey Rate means BRL/USD exchange rate for USD, expressed as the amount of BRL per one USD, for settlement in two Rio de Janeiro, Brasilia or Sao Paulo and New York Business Days, as published on EMTA’s web site (www.emta.org) at approximately 12:00 p.m. (Sao Paulo time), or as soon thereafter as practicable, on the BRL Valuation Date. The BRL Rate shall be calculated by EMTA (or a service provider EMTA may select in its sole discretion) pursuant to the EMTA BRL Indicative Survey Methodology (which means a methodology, dated as of March 1, 2004, as amended from time to time, for a centralized industry-wide survey of financial institutions that are active participants in the BRL/USD markets for the purpose of determining the EMTA BRL Indicative Survey Rate). The Company acknowledges that the Counterparty, acting directly or through a branch or an affiliate, may be requested to provide a quotation or quotations from time to time for the purpose of determining the EMTA BRL Indicative Survey Rate and such quotation may affect, materially or otherwise, the settlement of the Notes.
Sample 1

Examples of EMTA BRL Indicative Survey Rate in a sentence

  • The EMTA BRL Indicative Survey Commencing the Indicative Survey: On the calendar day after the lapse of any 30 day period during which valuation is either deferred or postponed (or both) (which calendar day is a Business Day or would have been a Business Day but for an Unscheduled Holiday), EMTA (or a service provider EMTA shall select in its sole discretion) shall conduct a survey of financial institutions for the purpose of determining the EMTA BRL Indicative Survey Rate for that day.

  • EMTA BRL Indicative Survey Rate Methodology Dated as of March 1, 2004 Capitalized terms not defined below are defined in the 1998 FX and Currency Option Definitions as published by the International Swaps and Derivatives Association, Inc.

  • Disruption Events and Fallbacks: Disruption Events: Price Source Disruption: Applicable Price Materiality: Applicable Primary Rate: BRL PTAX (BRL09) Secondary Rate: EMTA BRL Industry Survey Rate (BRLI2), or EMTA BRL Indicative Survey Rate (BRL 13), as the case may be.

  • Price Source Disruption: Applicable Price Materiality: Applicable Primary Rate: BRL09 Secondary Rate: EMTA BRL Industry Survey Rate (BRL 12), or EMTA BRL Indicative Survey Rate (BRL 13), as the case may be.

  • See Prospectus for details in the event that the EMTA BRL Indicative Survey Rate (BRL13) is unavailable.

  • The Applicable Exchange Rate on any date, means the PTAX800 on such date or, in the event the PTAX800 is unavailable, the EMTA BRL Industry Survey Rate (BRL12), and in the event the EMTA BRL Industry Survey Rate (BRL12) is unavailable, the EMTA BRL Indicative Survey Rate (BRL13).

  • Secondary Rate: EMTA BRL Industry Survey Rate (BRL 12), or EMTA BRL Indicative Survey Rate (BRL 13), as the case may be.

  • BRL13 The BRL13 is the EMTA BRL Indicative Survey Rate (BRL13),calculated if the R$ Ptax Rate is not available, which is the final Brazilian real/U.S. dollar specified rate of U.S. dollars, expressed as the amount of Brazilian reais per one U.S. dollar, published on EMTA’s website (which, at the date hereof, is located at http:// www.emta.org) for the Rate Calculation Date.


More Definitions of EMTA BRL Indicative Survey Rate

EMTA BRL Indicative Survey Rate means, in respect of any date, the USD/BRL foreign exchange rate for USD expressed as the amount of BRL per 1.00 USD, for settlement in two São Paulo and New York Business Days as published on EMTA's
Sample 1
EMTA BRL Indicative Survey Rate or “BRL 13” means that the BRL/USD Spot Rate for a for a BRL Valuation Date will be the Brazilian Real/U.S. Dollar specified exchange rate for U.S. Dollars, expressed as the amount of Brazilian Reais per one U.S. Dollar, for settlement in two Valuation Business Days, as published on EMTA’s web site (www.emta.org) at approximately 12:00 p.m. (São Paulo time), or as soon thereafter as practicable, on such for a BRL Valuation Date. The BRL/USD Spot Rate shall be calculated by EMTA (or a service provider EMTA may select in its sole discretion) pursuant to the EMTA BRL Indicative Survey Methodology (which means a methodology, dated as of March 1, 2004, as amended from time to time, for a centralized industry-wide survey of financial institutions that are active participants in the Brazilian Real/U.S. Dollar markets for the purpose of determining the EMTA BRL Indicative Survey Rate). “EMTA BRL Industry Survey Rate” or “BRL 12” means that the BRL/USD Spot Rate for a BRL Valuation Date will be the Brazilian Real/U.S. Dollar specified exchange rate for U.S. Dollars, expressed as the amount of Brazilian Reais per one U.S. Dollar, for settlement in two Valuation Business Days, as published on EMTA’s web site (www.emta.org) at approximately 3:45 p.m. (São Paulo time), or as soon thereafter as practicable, on such BRL Valuation Date. The BRL/USD Spot Rate shall be calculated by EMTA (or a service provider EMTA may select in its sole discretion) pursuant to the EMTA BRL Industry Survey Methodology (which means a methodology, dated as of March 1, 2004, as amended from time to time, for a centralized industry-wide survey of financial institutions in Brazil that are active participants in the Brazilian Real/U.S. Dollar spot markets for the purpose of determining the EMTA BRL Industry Survey Rate). “Maximum Days of Postponement” means 30 calendar days. “Price Materiality” means, in respect of a BRL Valuation Date, that the EMTA BRL Industry Survey Rate is available on such date and that BRL09 differs from the EMTA BRL Industry Survey Rate or the EMTA BRL Indicative Survey Rate by more than 3 per cent, provided however, that if there are insufficient responses to the EMTA BRL Industry Survey or the EMTA BRL Indicative Survey on the BRL Valuation Date the PriceMateriality will also be deemed to have been met.
Sample 1

Related to EMTA BRL Indicative Survey Rate

  • Approved clinical trial means a phase I, phase II, phase III, or phase IV clinical trial that is conducted in relation to the prevention, detection, or treatment of cancer or other life-threatening disease or Condition and is described in any of the following:

  • Phase III Clinical Trial means a human clinical trial of a product, the design of which is acknowledged by the FDA to be sufficient for such clinical trial to satisfy the requirements of 21 C.F.R. 312.21(c) (as amended or any replacement thereof), or a similar human clinical trial prescribed by the Regulatory Authority in a country other than the United States, the design of which is acknowledged by such Regulatory Authority to be sufficient for such clinical trial to satisfy the requirements of a pivotal efficacy and safety clinical trial.

  • First Indication means the first disease condition for which a particular Licensed Product has been approved by a Regulatory Authority.

  • Phase I Clinical Trial means the first study of a Product in humans the primary purpose of which is the determination of safety and which may include the determination of pharmacokinetic and/or pharmacodynamic profiles in healthy individuals or patients.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.